Published in J Clin Oncol on March 16, 2009
Current treatment options for local residual nasopharyngeal carcinoma. Curr Treat Options Oncol (2013) 0.99
A nomogram to predict loco-regional control after re-irradiation for head and neck cancer. Radiother Oncol (2014) 0.85
Reirradiation to the abdomen for gastrointestinal malignancies. Radiat Oncol (2009) 0.82
Development of a score predicting survival after palliative reirradiation. J Oncol (2014) 0.79
Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic. Radiat Oncol (2016) 0.79
Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers. Oral Oncol (2015) 0.78
When is re-irradiation in head and neck squamous cell carcinoma not indicated? Eur Arch Otorhinolaryngol (2013) 0.77
A Retrospective Evaluation of Clinical Profile of Second Primary Head and Neck Cancer. J Clin Diagn Res (2016) 0.75
Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck. Front Oncol (2016) 0.75
Salvage surgery for locoregional recurrences of advanced pharyngolaryngeal squamous cell carcinoma after organ preservation failure. Acta Otorhinolaryngol Ital (2014) 0.75
Impact of Flap Reconstruction on Radiotoxicity After Salvage Surgery and Reirradiation for Recurrent Head and Neck Cancer. Ann Surg Oncol (2016) 0.75
Reirradiation using robotic image-guided stereotactic radiotherapy of recurrent head and neck cancer. J Radiat Res (2016) 0.75
Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol (2016) 0.75
The P38α rs3804451 Variant Predicts Chemotherapy Response and Survival of Patients with Non-Small Cell Lung Cancer Treated with Platinum-Based Chemotherapy. Transl Oncol (2016) 0.75
Reirradiation with IMRT for recurrent head and neck cancer: A single-institutional report on disease control, survival, and toxicity. Rep Pract Oncol Radiother (2017) 0.75
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med (2010) 4.00
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort study. Ann Intern Med (2011) 3.83
Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. J Immunol (2009) 3.23
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data. Diabetes (2012) 3.11
Molecular staging for survival prediction of colorectal cancer patients. J Clin Oncol (2005) 2.88
Identifying women with dense breasts at high risk for interval cancer: a cohort study. Ann Intern Med (2015) 2.46
Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res (2004) 2.33
Lipid accumulation and dendritic cell dysfunction in cancer. Nat Med (2010) 2.21
Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-cell lung cancer. J Clin Oncol (2008) 2.18
Multi-platform, multi-site, microarray-based human tumor classification. Am J Pathol (2004) 2.14
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer. J Clin Oncol (2009) 2.13
Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Ann Surg Oncol (2008) 2.11
PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. Int Immunol (2009) 2.10
Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates? J Natl Cancer Inst (2013) 1.81
Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res (Phila) (2010) 1.68
Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance. Mol Cancer Ther (2008) 1.65
Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors. Blood (2007) 1.54
Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. JAMA Intern Med (2013) 1.51
Sun protection at elementary schools: a cluster randomized trial. J Natl Cancer Inst (2010) 1.50
Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol (2007) 1.49
Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model. Cancer Res (2003) 1.47
Epstein-Barr and other herpesvirus infections in patients with early onset type 1 diabetes treated with daclizumab and mycophenolate mofetil. Clin Infect Dis (2012) 1.47
The FA/BRCA pathway is involved in melphalan-induced DNA interstrand cross-link repair and accounts for melphalan resistance in multiple myeloma cells. Blood (2005) 1.43
Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activation. PLoS One (2010) 1.41
Systems biology modeling of the radiation sensitivity network: a biomarker discovery platform. Int J Radiat Oncol Biol Phys (2009) 1.38
Distinguishing screening from diagnostic mammograms using Medicare claims data. Med Care (2014) 1.37
Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation. Br J Haematol (2003) 1.31
Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma. Cancer Res (2009) 1.25
A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. Int J Radiat Oncol Biol Phys (2009) 1.24
A comprehensive geriatric intervention detects multiple problems in older breast cancer patients. Crit Rev Oncol Hematol (2004) 1.23
Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm (2008) 1.23
Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma. Arch Otolaryngol Head Neck Surg (2009) 1.19
Effect of Ack1 tyrosine kinase inhibitor on ligand-independent androgen receptor activity. Prostate (2010) 1.19
Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol (2009) 1.19
Survival outcomes of squamous cell carcinoma arising from sinonasal inverted papilloma: report of 6 cases with systematic review and pooled analysis. Am J Otolaryngol (2008) 1.16
Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer. Cancer (2008) 1.15
Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg (2007) 1.15
Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome. Cancer (2010) 1.14
Thyroid carcinoma. J Natl Compr Canc Netw (2007) 1.13
Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway. Cancer Res (2003) 1.12
Lipomatous tumors of the parapharyngeal space: case series and literature review. Arch Otolaryngol Head Neck Surg (2010) 1.08
Testicular defense systems: immune privilege and innate immunity. Cell Mol Immunol (2014) 1.05
Cell adhesion to fibronectin (CAM-DR) influences acquired mitoxantrone resistance in U937 cells. Cancer Res (2006) 1.05
Thyroid carcinoma. J Natl Compr Canc Netw (2005) 1.04
Synchronous global assessment of gene and protein expression in colorectal cancer progression. Genomics (2005) 1.04
Curcumin modulates miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7 breast cancer cell proliferation. Phytother Res (2014) 1.04
Down-regulation of Bax-interacting factor-1 in colorectal adenocarcinoma. Cancer (2008) 1.03
Tipifarnib and bortezomib are synergistic and overcome cell adhesion-mediated drug resistance in multiple myeloma and acute myeloid leukemia. Clin Cancer Res (2006) 1.02
On the lateral structure of model membranes containing cholesterol. Biochim Biophys Acta (2008) 1.01
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer. Clin Cancer Res (2008) 1.01
A novel folate-modified self-microemulsifying drug delivery system of curcumin for colon targeting. Int J Nanomedicine (2012) 1.01
Ack1 tyrosine kinase activation correlates with pancreatic cancer progression. Am J Pathol (2012) 1.00
Performance of HbA1c as an early diagnostic indicator of type 1 diabetes in children and youth. Diabetes Care (2012) 0.99
EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions. Clin Cancer Res (2013) 0.99
Cyclooxygenase-2 expression in right- and left-sided colon cancer: a rationale for optimization of cyclooxygenase-2 inhibitor therapy. Clin Colorectal Cancer (2004) 0.97
Medullary carcinoma. J Natl Compr Canc Netw (2010) 0.97
Assessing health care use and cost consequences of a new screening modality: the case of digital mammography. Med Care (2012) 0.93
Sampling strategies for tissue microarrays to evaluate biomarkers in ovarian cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.92
Penetrating craniofacial injury inflicted by a knife. J Trauma (2008) 0.91
Activation of the serine/threonine protein kinase AKT during the progression of colorectal neoplasia. Clin Colorectal Cancer (2007) 0.91
Validation of a Medicare Claims-based Algorithm for Identifying Breast Cancers Detected at Screening Mammography. Med Care (2016) 0.91
Effects of progressive muscular relaxation training on anxiety, depression and quality of life of endometriosis patients under gonadotrophin-releasing hormone agonist therapy. Eur J Obstet Gynecol Reprod Biol (2012) 0.89
Mucosal melanoma of the head and neck. J Natl Compr Canc Netw (2012) 0.89
Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age. Cancer (2013) 0.89
Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma. Head Neck (2013) 0.88
Bax-interacting factor-1 expression in prostate cancer. Clin Genitourin Cancer (2008) 0.87
Cancer in nonagenarians: profile, treatments and outcomes. Crit Rev Oncol Hematol (2010) 0.87
Patterns of care and survival in cancer patients with cognitive impairment. Crit Rev Oncol Hematol (2009) 0.87
Clinical and biological significance of nemo-like kinase expression in glioma. J Clin Neurosci (2010) 0.86
Effects of digital mammography uptake on downstream breast-related care among older women. Med Care (2012) 0.86
Low-voltage, high-extinction-ratio, Mach-Zehnder silicon optical modulator for CMOS-compatible integration. Opt Express (2012) 0.85
Substantially reduced expression of PIAS1 is associated with colon cancer development. J Cancer Res Clin Oncol (2009) 0.85
Influence of melatonin on cerebrovascular proinflammatory mediators expression and oxidative stress following subarachnoid hemorrhage in rabbits. Mediators Inflamm (2010) 0.85
A general approach to spirolactonized Si-rhodamines. Chem Commun (Camb) (2014) 0.84
Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI. J Gen Intern Med (2013) 0.84
Activation of the serine/threonine protein kinase Akt during the progression of Barrett neoplasia. Hum Pathol (2007) 0.84
Risk factors for percutaneous endoscopic gastrostomy tube placement during chemoradiotherapy for oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg (2013) 0.84
Anti-inflammatory Activity of Magnesium Isoglycyrrhizinate Through Inhibition of Phospholipase A2/Arachidonic Acid Pathway. Inflammation (2015) 0.83
The role of connexin 43 and hemichannels correlated with the astrocytic death following ischemia/reperfusion insult. Cell Mol Neurobiol (2013) 0.83
Risk of advanced-stage breast cancer among older women with comorbidities. Cancer Epidemiol Biomarkers Prev (2012) 0.83
Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest. Breast Cancer Res Treat (2009) 0.82
Assessment of elementary school students' sun protection behaviors. Pediatr Dermatol (2009) 0.81
Successful management of subglottic stenosis during the third trimester of pregnancy. J Bronchology Interv Pulmonol (2010) 0.81
Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography. Breast Cancer Res Treat (2013) 0.81
Preparation of superparamagnetic Fe3O4@alginate/chitosan nanospheres for Candida rugosa lipase immobilization and utilization of layer-by-layer assembly to enhance the stability of immobilized lipase. ACS Appl Mater Interfaces (2012) 0.80
Proof of concept of directed OR/NOR and AND/NAND logic circuit consisting of two parallel microring resonators. Opt Lett (2011) 0.80
Microring-resonator-based four-port optical router for photonic networks-on-chip. Opt Express (2011) 0.80
Measurement of phospholipids may improve diagnostic accuracy in ovarian cancer. PLoS One (2012) 0.80
Skin irritation and the inhibition effect on HSV-1 in vivo of penciclovir-loaded microemulsion. Int Immunopharmacol (2010) 0.80
Toll-like receptor 3 and RIG-I-like receptor activation induces innate antiviral responses in mouse ovarian granulosa cells. Mol Cell Endocrinol (2013) 0.80
Polyethylene glycol (PEG) hydrogel dural sealant and collagen dural graft matrix in transsphenoidal pituitary surgery for prevention of postoperative cerebrospinal fluid leaks. J Clin Neurosci (2011) 0.80
Severe hypoalbuminemia at day 90 predicts worse nonrelapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome. Biol Blood Marrow Transplant (2010) 0.80
Simultaneous implementation of XOR and XNOR operations using a directed logic circuit based on two microring resonators. Opt Express (2011) 0.79
Functional analysis of BADH gene promoter from Suaeda liaotungensis K. Plant Cell Rep (2007) 0.79
Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes. J Clin Virol (2013) 0.79
Effect of docosahexaenoic acid supplementation on inflammatory cytokine levels in infants at high genetic risk for type 1 diabetes. Pediatr Diabetes (2014) 0.79